Status:
COMPLETED
Clinical Evaluation of a New Aspheric Intraocular Lens.
Lead Sponsor:
Bausch & Lomb Incorporated
Conditions:
Cataract
Eligibility:
All Genders
50-85 years
Phase:
PHASE4
Brief Summary
This study evaluates the visual performance and occurrence of posterior capsular opacification after implantation of a new aspherical intraocular lens compared with a control spherical lens of otherwi...
Eligibility Criteria
Inclusion
- Patients must have a clinically documented diagnosis of bilateral cataract (either cortical, nuclear, subcapsular or a combination) liable to benefit from standard cataract surgery.
- Patients must be undergoing primary cataract surgery with IOL in-the-bag implantation, requiring a IOL power from 10 to 30 diopters.
Exclusion
- Patients with corneal damage.
- Patients with any anterior segment pathology for which extracapsular phacoemulsification cataract surgery would be contraindicated.
- Patients with any ocular pathology, other than the cataract, having repercussions on visual function:
Key Trial Info
Start Date :
January 1 2004
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
January 1 2008
Estimated Enrollment :
75 Patients enrolled
Trial Details
Trial ID
NCT00786565
Start Date
January 1 2004
End Date
January 1 2008
Last Update
December 12 2011
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.